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An Insight into Substrate-Dependent Fluorination of some
Highly Substituted Alicyclic Scaffolds
Lora´nd Kiss,*[a] A´gnes Petrovszki,[a] Csaba Vass,[a] Melinda Nonn,[b] Reijo Sillanpa¨a¨,[c]
Matti Haukka,[c] Santos Fustero,[d] and Ferenc Fu¨lo¨p[a, b]
The substrate-dependent fluorination of some highly-function-
alized cyclopentane derivatives with multiple chiral centers has
been investigated. The key steps of the stereocontrolled
syntheses are the oxidative cleavage of the ring carbon–carbon
double bond of readily available diexo or diendo norbornene b-
amino acid derivatives followed by transformation of the
resulted dialdehyde stereoisomers by reduction. Finally, sub-
strate-directable chemodifferentiation of different types of
hydroxy groups under fluorination procedures gave various
densely functionalized alicyclic derivatives or heterocycles.
Introduction
As a result of the increasing biomedical relevance of fluorine-
containing biomolecules including heterocycles, their syntheses
and use as fluorinated building blocks, highly-functionalized
alicyclic scaffolds and natural product analogues have received
significant interest among medicinal and organic chemists in
recent years. The introduction of one or more fluorine atoms
into organic moieties may change dramatically their chemical,
physical and biological properties. Accordingly, there is a
growing interest in the development of selective, efficient
routes to access novel fluorinated building blocks.[1]
Among the various fluorinated scaffolds, fluorinated amino
acids are of high relevance in pharmaceutical chemistry. A
number of fluorinated amino acids are known to be antibacte-
rial, antifungal and antitumoural agents. Furthermore, they are
valuable building elements in peptide-based drug research.[2]
Noteworthy that cyclic b-amino acids (eg. cispentacin, icofun-
gipen, tilidin, etc.) and their derivatives, less abundant than
their a-analogues, have acquired high significance recently
both in medicinal chemistry and peptide research.[3] Fluorinated
representatives of this class of compounds, consequently,
might play a significant role in pharmaceutical research.
Relevant information for fluorinated cyclic b-amino acids are
found in reference.[4]
Results and Discussion
The aim of the present research was to extend our earlier
findings[5] on substrate dependent fluorinations, by investigat-
ing the transformation of various hydroxy functionalized cyclo-
pentane b-amino acid derivatives into highly-substituted
alicyclic or heterocyclic stereoisomers under fluorination con-
ditions with the intention to explore the chemical behavior of
these diversely substituted patterns. The synthetic routes
towards various building blocks with multiple chiral stereo-
centers included stereocontrolled hydroxylation of the ring
olefinic bond of the readily available diexo or diendo norbor-
nene b-amino acids through oxidative ring cleavage and
reduction, followed by fluorination of the hydroxylated scaf-
folds by chemodifferentiation (Scheme 1).
In order to investigate the fluorination of polyfunctionalized
alicyclic scaffolds, first racemic cyclopentane diformyl amino
esters ()-2a[6] and ()-2b[5] were synthesized through olefin
bond ring cleavage of bicyclic diexo amino acid ()-1. These
were then transformed into functionalized diol derivatives ()-
3a and ()-3b by reducing the formyl group with NaBH4. For
the creation of fluoromethylene functions on the skeleton of
the N-benzoyl- or N-Cbz-protected cyclopentane b-amino acid,
bis-hydroxymethylenic amino esters ()-3a and ()-3b were
submitted to monofluorination through hydroxy–fluorine ex-
change with Deoxofluor.
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Scheme 1. Schematic route to chemoselective transformation of highly-
functionalized cyclopentanes by fluorination.
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N-Benzoyl-protected amino ester ()-3a underwent fluori-
nation upon reacting with various amounts of Deoxofluor in
CH2Cl2 at varied temperatures (-15 8C, 0 8C or 20 8C). The highest
yield (74%) was achieved with 2.5 equiv. Deoxofluor at room
temperature. However, contrary to the expected amino ester
containing two fluormethylene groups, monofluorinated heter-
ocyclic derivative ()-4a was formed resulting from chemo-
differentiation between the two hydroxyl groups. This chemo-
discrimination can be explained by the neighboring assistance
of the amide group of ()-3a. It is obvious, that the hydroxy
group of the hydroxymethylene function at position 5 under-
went the expected fluorination. The other hydroxymethylene
moiety in position 3, in turn, after transformation with
Deoxofluor into the corresponding leaving group, was involved
in cyclization. This took place via the anchimeric effect of the
amide function via O-nucleophilic intramolecular attack to the
corresponding fluorinated intermediate T-1 leading to oxazine
derivative ()-4a (Scheme 2).
A different chemical behavior was observed when diol ()-
3b with N-Cbz protecting group was subjected to fluorination.
When performing the reaction of ()-3b with Deoxofluor under
various conditions (-15 8C, 0 8C or 20 8C), both hydroxyl groups
underwent fluorination providing exclusively difluorinated
derivative ()-4b (Scheme 2, Figure 1). Noteworthy that in the
reaction with only 1 equiv. of Deoxofluor reagent, difluorinated
compound ()-4b and unreacted material were detected.
Next, “all-cis” diformyl amino ester ()-6,[7] accessed from
diendo norbornene amino acid ()-5, was subjected to
reduction with NaBH4 in various solvents (EtOH, THF)
(Scheme 3). When the reduction of ()-6 was performed in THF
at 20 8C, the process resulted in formyl group reduction
followed by intramolecular cyclization to amino lactone ()-7
as the single product (Scheme 3, Figure 2).
The lactonization during reduction could be prevented by
reacting ()-6 with NaBH4 at 0 8C for 30 min to have bis-
hydroxymethyl-substituted amino ester ()-9 as the sole
product (Scheme 3, Figure 4. However, when running the
reduction at 0 8C for a longer time, lactonization also took place
to give a significant amount of ()-7 alongside ()-9.
Next amino lactone ()-7 possessing one hydroxy group
was submitted to fluorination with Deoxofluor. However, either
at reduced temperature (-15 8C) or at room temperature,
intramolecular heterocyclization and concomitant deoxygena-
tion occurred leading to ester ()-8 (Scheme 3, Figure 3).
In contrast to the fluorination of dihydroxylated amino ester
()-3 (Scheme 2), the “all-cis” amino ester ()-9 on treatment
with Deoxofluor under various conditions did not provide any
Scheme 2. Fluorination of dihydroxylated ethyl b-aminocyclopentanecarbox-
ylate ()-3a and ()-3b.
Figure 1. X-ray structure of compound ()-4b.
Scheme 3. Fluorination of amino lactone ()-7 and dihydroxylated ethyl b-
aminocyclopentanecarboxylate ()-9.
Figure 2. X-ray structure of compound ()-7.
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fluorinated product. Rather, only decomposed materials could
be detected.
In order to increase the number of stereoisomers of
hydroxylated cyclopentanes, endo,exo amino ester ()-10,[8]
synthesized from diexo norbornene amino ester ()-1, was
submitted to ring cleavage. First, it was transformed by
dihydroxylation into ()-11, followed by oxidative ring opening
achieved with NaIO4 affording diformylated cyclopentane
amino ester ()-12. Reduction of the aldehyde functions carried
out with NaBH4 under varied conditions (THF and EtOH as
solvents, 15 8C, 0 8C or 20 8C) furnished exclusively in all cases
aminolactone ()-13 by cyclization. Deoxofluorination of ()-
13, analogously to ()-7 resulted in tricyclic compound ()-14
a new stereoisomer of ()-8 (Scheme 4).
In continuation of our investigation on the fluorination of
hydroxylated cyclopentane stereoisomers, a novel dihydroxy-
lated amino ester ()-16 was prepared from exo,endo norbor-
nene b-amino ester ()-15. Then oxidative ring cleavage of ()-
16 afforded diformylated cyclopentane stereoisomer ()-17,
which, in turn on treatment with NaBH4, underwent reduction
and gave bis-hydroxymethylenated derivative ()-18 a novel
stereoisomer of ()-3a and ()-9 (Scheme 5, Figure 5).
Fluorination of compound ()-18 accomplished with vari-
ous equivalents of Deoxofluor at different temperatures (-15 8C,
0 8C or 20 8C) provided by intramolecular cyclization through
neighboring group participation oxazine derivative ()-18, a
novel stereoisomer of ()-4a as the sole product (Scheme 5).
Conclusions
Starting from readily available diexo- or diendo-norbornene b-
amino acids, selective fluorination of a number of stereo-
Figure 3. X-ray structure of compound ()-8..
Figure 4. X-ray structure of compound ()-9.
Scheme 4. Fluorination of hydroxylated lactone ()-13.
Scheme 5. Fluorination of dihydroxylated ethyl b-aminocyclopentanecarbox-
ylate ()-18.
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isomers of highly functionalized hydroxylated cyclopentane
derivatives with multiple stereogenic centers has been eval-
uated. Alicyclic scaffolds with varied hydroxylation patterns
obtained by oxidative olefinic bond cleavage and reduction
were investigated in view of chemoselective monofluorination.
The substrate-dependent chemodifferentiation of hydroxy
groups under fluorination conditions involved either hydroxy–
fluorine exchange or the anchimeric effect of the amide
functions and led selectively to novel highly-functionalized
molecular entities with multiple stereocenters. The nature of
the N-protecting group plays a decisive role in the final result
of selective fluorination. The prepared building blocks with
high chemical diversity might be regarded as interesting
heterocyclic or aminolactone scaffolds for further transforma-
tions, which are currently investigated in our laboratory.
Supporting Information Summary
General procedure for the synthesis and spectral data of all the
synthesized compounds associated with this article will be
available as supporting information.
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Figure 5. X-ray structure of compound ()-18.
Full Papers
3052ChemistrySelect 2017, 2, 3049–3052  2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
